Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.

Blood Adv · 2023 · PMC10440463 · PMID 37352262

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP = .07so close (0.05 < p ≤ 0.1)

There was higher incidence of grade 3 or 4 aGVHD with mini-MTX/MMF, that is, 13% compared with 4% in the full-MTX group; however, this did not reach statistical significance (HR 3.90; 95% CI, 0.83-18.3; P = .07; Figure 1 B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.